✦ LIBER ✦

Human tumor clonogenic assay in osteosarcoma for evaluation of clinical efficacy of anti-cancer drugs

✍ Scribed by Katsuro Tomita; Akio Yokogawa; Susumu Nomura

Publisher: Springer
Year: 1986
Tongue: English
Weight: 400 KB
Volume: 18
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00262282

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of anticancer drug schedule d

Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay

✍ Ruth Ludwig; David S. Alberts; Thomas P. Miller; Sydney E. Salmon 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 595 KB

In vitro evaluation of anticancer drugs

In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay

✍ Katsuhiro Inoue; Taketo Mukaiyama; Ikuo Mitsui; Makoto Ogawa 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 533 KB

Application of an in vitro antimetabolic

Application of an in vitro antimetabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity

✍ Ornella Sanfilippo; Rosella Silvestrini; Nadia Zaffaroni; Luigi Piva; Giorgio Pi 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

Comparison of 131I-labelled anti-episial

Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts

✍ Carla F. M. Molthoff; Herbert M. Pinedo; Hennie M. M. Schlüper; Derk H. Rutgers; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 772 KB

Three human ovarian cancer xenografts of different origin and grown S. C. in nude mice as well-established tumors were studied for their sensitivity to cisplatin (CDDP), cyclophosphamide (CTX), '3'I-labelled anti-episialin monoclonal antibody (MAb) I39H2, or external-beam radiotherapy. The maximum t

Soluble E-selectin in cancer patients as

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

✍ Barbara D. Wamil; Gary B. Thurman; Hakan W. Sundell; Russel F. DeVore; Gail Wake 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 703 KB

Efficacy of SSG and SSG/IFNα2 against hu

Efficacy of SSG and SSG/IFNα2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action

✍ Jing Li; Daniel J. Lindner; Carol Farver; Ernest C. Borden; Taolin Yi 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 424 KB